Pro-growth policies could persuade some hesitant retail investors to re-enter the market, David Lebovitz says. » Read More
By: Giovanny Moreano
A month later, Deutsche Bank says buy CSX stock. » Read More
By: Lauren Thomas
Shares of weight loss service Nutrisystem skyrocketed after the company reported fourth-quarter earnings and full-year guidance that topped expectations. » Read More
Jim Cramer was thrilled to see Warren Buffett’s refreshing take that Apple is more than just a technology company. » Read More
Former Treasury Secretary Larry Summers explains why Trump's tax proposals could be detrimental to the global economy.
Barracuda's active subscribers jumped by 15 percent and billings increased 13 percent from a year earlier.
Some of the names on the move ahead of the open.
Chipotle shares ticked higher Tuesday, reversing an earlier decline of roughly 4 percent.
The "Fast Money" traders share their first moves for the market open.
Investors need to watch only one number to figure out what returns are going to look like, Gross says.
Goldman shares are up 34 percent versus the S&P 500's 6 percent return since the Nov. 8 election.
Liquidity is one reason ETFs appeal to many, but advisors say they only make sense if vetted and employed properly.
"This is still a cash machine," strategist Max Wolff says of Apple, which hit a 52-week high on Monday.
If the dollar keeps rising, investors may want to rethink consumer staples in their portfolios.
Shares of Acuity Brands dropped nearly 15 percent after the lighting solutions provider reported weaker-than-expected quarterly results.
One top technician says cruise stocks are the way to play the consumer.
Todd Gordon of TradingAnalysis.com sees the dollar rally fading, and he shows investors how to play it.
Hans Bishop gives an update on Juno Therapeutics in an exclusive interview with CNBC's Meg Tirrell.
Gold just saw its longest outflow streak in three years, according to a recent BofAML report.
Protectionist policies by President-elect Donald Trump could result in jobs losses, as companies use machines instead of human labor.
Investors are putting too much pressure on Goldman Sachs to carry the Dow to 20,000, CNBC's Jim Cramer said on Monday.
Ariad Pharmaceuticals investors are having a good day.
China has quietly ushered in a series of new measures aimed at better managing the value of its currency, the yuan.
There's a good chance that most companies will not be doing any dramatic fist pumps about earnings in the new year.
Get the best of CNBC in your inbox